Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene

Leuk Lymphoma. 2011 Sep;52(9):1815-7. doi: 10.3109/10428194.2011.580477. Epub 2011 May 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bexarotene
  • Female
  • Humans
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Lymphoma, T-Cell, Peripheral / genetics
  • Lymphoma, T-Cell, Peripheral / pathology
  • Middle Aged
  • Retinoid X Receptors / agonists*
  • Tetrahydronaphthalenes / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Retinoid X Receptors
  • Tetrahydronaphthalenes
  • Bexarotene